Recurrent Breast Cancer Completed Phase 1 / 2 Trials for Suramin (DB04786)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00054028Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast CancerTreatment